Technology

Molecular Templates

$11.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.36%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MTEM and other stocks, options, and ETFs commission-free!

About MTEM

Molecular Templates, Inc. Common Stock, also called Molecular Templates, is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX. The listed name for MTEM is Molecular Templates, Inc. Common Stock.

CEO
Eric E. Poma
Employees
168
Headquarters
Austin, Texas
Founded
2000
Market Cap
531.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
264.98K
High Today
$11.40
Low Today
$10.76
Open Price
$11.26
Volume
315.19K
52 Week High
$19.12
52 Week Low
$7.51

Collections

MTEM Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

NNY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure